Why the study?
Repeated measurements of heart rate variability (HRV) are more relevant than a single measurement for predicting prognosis but have been less addressed in chronic hemodialysis patients.
Does repeated measurement of heart rate variability predict long-term mortality in chronic hemodialysis patients?
Does repeated measurement of heart rate variability predict long-term mortality in chronic hemodialysis patients?
Repeated measurements of heart rate variability can independently predict long-term cardiovascular and infection-associated mortality in chronic hemodialysis patients.
Repeated HRV monitoring may aid mortality risk stratification in hemodialysis; leaves open whether it warrants routine clinical adoption.
The repeated measurements of heart rate variability (HRV) is more relevant than a single HRV measurement in predicting patient prognosis but is less addressed previously. This prospective study aimed to investigate the association between repeated measurements of HRV and long-term mortality in chronic hemodialysis patients. The 164 patients (65.0 ± 13.1 years; woman, 57.3%) were enrolled from June 1, 2010, to August 31, 2010, and received four HRV measurements (before and during the index hemodialysis session) after the enrollment. The baseline characteristic and clinical variables, including mortality, were documented. The joint modeling method and Cox regression were used for statistical analyses. After an 8-year follow-up, 79 patients expired, and 85 patients survived. We found that higher normalized high-frequency (nHF) (hazard ratio [HR] 1.033) as well as lower very-low-frequency (HR 0.990), Variance (HR 0.991), normalized low-frequency (HR 0.999, P = 0.006), and low-frequency/high-frequency ratio (HR 0.796) were independent predictors for cardiovascular mortality. Whereas the independent predictors for infection-associated mortality included higher nHF (HR 1.033) as well as higher age (HR 19.29) and lower serum albumin (HR 0.01, P = 0.001). (all P < 0.001 unless otherwise stated) In conclusion, HRV measurement predicts long-term mortality among hemodialysis patients.
No takes yet. Share an insight, caveat, or question.
Chang et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: